BBIO

BBIO R&D Expenses

$530.96MTTM · USD

Period ending:

BBIO FY R&D ExpensesUSD
BBIO FY R&D Expenses2017-12-31: $30.56M2018-12-31: $140.07M2019-12-31: $209.95M2020-12-31: $337.05M2021-12-31: $451.02M2022-12-31: $399.46M2023-12-31: $455.71M2024-12-31: $506.46M2025-12-31: $477.54M$506.46M$0.00
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

BBIO r&d expenses history

Research and development spending. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Bridgebio Pharma Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
477,536,000
506,461,000
455,711,000
399,462,000
451,024,000
337,047,000
209,947,000
140,073,000
30,556,000

Compare r&d expenses

All BBIO financial metrics · BBIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.